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Abstract
The placental-decidual interaction through invading trophoblasts determines whether a
physiological transformation of the uterine spiral arteries is established or not. Trophoblast-
orchestrated artery remodeling is central to normal placentation. Dysregulated uteroplacental
interaction and vascular remodeling are thought to be associated with the molecular events
underlying the pathology of late pregnancy anomalies including preeclampsia. Although the exact
gestational age at which trophoblast invasion ceases is not known, it remains unclear whether late
pregnancy trophoblasts retain the ability to transform the uterine arteries. Here, we have developed
a dual cell, in vitro culture system that mimics the vascular remodeling events during normal
pregnancy. We demonstrate that first and third trimester trophoblasts respond differentially to
interactive signals from endothelial cells when cultured on matrigel. Term primary trophoblasts or
immortalized third trimester extravillous TCL1 trophoblasts not only fail to respond to signals
from endothelial cells but also inhibit endothelial cell tube formation. In contrast, HTR8 cells,
representing a first trimester trophoblast cell line with invasive properties, undergo spontaneous
migration and synchronize with the endothelial cells in a capillary network. This disparity in
behavior was confirmed in vivo using a matrigel plug assay. Poor expression of VEGF C and
VEGF receptors coupled with high E-cadherin expression by term primary trophoblasts and TCL1
cells contributed to their restricted interactive and migratory properties. We further show that the
kinase activity of VEGF R2 is essential for proactive cross-talk by HTR8 cells. This unique
behavior of first trimester trophoblasts in the presence of endothelial cells offers a potential
approach to study cell-cell interactions and to decipher modulatory components in the serum
samples from adverse pregnancy outcomes.
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1. Introduction
Pregnancy triggers dynamic changes in the human endometrium that allow its optimal
decidualization and functional interaction with invading trophoblasts [1]. These changes are
characterized by the highly choreographed events of hormonal regulation, immune cell
recruitment, and invasion of the decidua by trophoblasts. Extravillous trophoblast invasion is
a hallmark of normal pregnancy. Its dysregulation is associated with poor spiral artery
remodeling and multiple disorders including preeclampsia, intrauterine growth restriction
(IUGR), and preterm labor or preterm PROM [2–5]. The process of spiral artery
transformation into wider capacitance vessels allows increased blood flow and nutrients to
the fetus [6,7]. Although the exact gestational age at which trophoblast remodeling of the
spiral arteries occur and ceases is ambiguous, this dynamic window is believed to be
between first and second trimesters. On the other hand, shallow trophoblast invasion is
thought to result in deficient remodeling and ischemia at the maternal-fetal interface,
causing release of a variety of inflammatory factors from the placenta which affects
maternal vascular homeostasis [8].
Since preeclampsia, IUGR, preterm labor or preterm PROM are late pregnancy maladies, we
have addressed in this study the question of why trophoblasts from third trimester do not
overcome the invasive deficiency associated with these disorders. It is not clear whether
third trimester trophoblasts retain the ability to invade the decidua and respond to trophic
signals from their surroundings to transform spiral arteries. Previous studies from our
laboratory have demonstrated that first trimester and third trimester trophoblasts differ in the
production of inflammatory and anti-inflammatory cytokines with significant attenuation of
IL-10 at term [9]. Coincidently, IL-10 has been shown to protect against macrophage-
mediated inhibition of trophoblast invasion [10]. It is then plausible that third trimester
trophoblasts may be defective in migration and cell-cell interaction. Although recent studies
have provided ample evidence for well choreographed interactions between resident
endothelial cells, uterine NK (uNK) cells and first trimester trophoblasts [11,12,13], the
molecular and biochemical signature features that distinguish third trimester trophoblasts
need to be characterized.
We have utilized serum from normal pregnant women to impart physiological environment
to promote interactions between immortalized first trimester (HTR8) and third trimester
(TCL1) trophoblasts with extravillous trophoblast properties, term primary trophoblasts and
endothelial cells. We hypothesized that in response to normal pregnancy serum (NPS),
TCL1 cells or term primary trophoblasts would interact poorly with endothelial cells
compared to first trimester HTR8 trophoblasts. In this study, we have used dual cell culture
assays on matrigel to dissect the influence of endothelial cells in regulating trophoblast
migration and invasion that closely mimic spiral artery remodeling. This study offers a
robust approach to decipher biochemical components that are modified or uniquely
expressed in non-invading third trimester trophoblasts.
2. Materials and Methods
2.1. Serum Collection
The use of human blood was approved by the Institutional Review Boards of Women and
Infants Hospital of Rhode Island, USA and Linkoping University Hospital, Linkoping,
Sweden. Informed consent was obtained from women with normal pregnancies between 36–
40 weeks of gestation. Blood samples (9–10 ml) were centrifuged at 2700 rpm for 10 min to
obtain serum and aliquots were stored at −80° C until further use.
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2.2. Isolation of term primary trophoblasts
Cytotrophoblasts were isolated from term placental tissue as previously described [9].
Placental tissue was digested with decreasing concentrations of trypsin-DNase 1 (trypsin, 1
mg/ml; and DNase, 1.5 mg/ml) at least four times at 37°C for 20 min each. The cell mass
collected was treated with a red blood cell 7.3) for 5 min at lysis buffer (0.15 M NH4Cl, 1
mM KHCO3, and 0.1 mM EDTA (pH room temperature with constant shaking.
Cytotrophoblasts isolated in this manner were stained for cytokeratins or CD45 (a marker
for immunocytes) to confirm their purity (>95%).
2.3. Trophoblast cell lines and cell culture
We used immortalized first trimester trophoblast cell lines HTR8 and Swan 71 with
properties of invasive extravillous cytotrophoblasts, and the third trimester extravillous
TCL1 cell line [14, 15, 16]. Both primary trophoblasts and cell lines were maintained in
Roswell Park Memorial Institute (RPMI) 1640 media purchased from Gibco (Gaithersburg,
MD, USA) supplemented with 10% fetal bovine serum, 2mM L-glutamine (Gibco BRL),
100U/ml penicillin (Gibco BRL) and 0.1mg/ml streptomycin (Gibco BRL). Cell lines were
grown to ~80% confluence and all cells from limited passages were used in the study.
Freshly isolated primary trophoblasts cultured overnight were used for the studies. Human
umbilical cord endothelial cells (HUVEC) and human uterine endothelial cells (HUtEC)
were obtained from Cambrex (East Rutherford, NJ, USA) and cultured in EBM-2 medium
(Cambrex, East Rutherford, NJ, USA). All cells were maintained in standard culture
conditions of 5% CO2 at 37°C.
2.4. Three dimensional dual cell co-culture assay
Growth factor-reduced Matrigel (BD Biosciences, San Diego, CA, USA) was thawed
overnight at 4°C and mixed to homogeneity. Culture plates (48-well) were coated with 0.1
ml of Matrigel and allowed to gelatinize at 37°C for 30 min. Trophoblasts or endothelial
cells (2.5 × 104), labeled with cell tracker green CMFDA or cell tracker orange CMTMR
(Molecular Probes, Eugene, OR, USA), respectively, were singly cultured or co-cultured
(1:1) in the presence of 10% normal pregnancy serum (NPS). The number and ratios of the
trophoblasts and endothelial cells for optimal interaction was based on preliminary studies
using different ratios of cells. The cellular interactions and endothelial cell-directed tube
formation by trophoblasts were monitored and recorded after 10–12 hrs of incubation using
the fluorescence microscopy (4× and 10× magnification, Nikon Eclipse TS 100 coupled
with CCD camera). The average number of tubes/vacuoles formed was quantified by
counting the number of vacuoles formed in four different fields, by two independent
investigators. A total of 8 different NPS samples were tested.
2.5. VEGF R2 kinase inhibitor SU1498
HTR8 cells were incubated with SU1498 (Calbiochem, CA, USA), a potent and selective
inhibitor of VEGF R2 kinase activity [17] at 10 or 20 uM concentration, for six hours in
presence of NPS. The cells were washed, labeled with cell tracker green, trypsinized and co-
cultured with endothelial cells (HUVEC or HUtEC) on matrigel and the tube formation was
initiated with the addition of 10% NPS. The morphological changes observed were recorded
as mentioned earlier.
2.6. Reverse transcription-polymerase chain reaction (RT-PCR) assay
Total RNA was isolated with RNeasy Kit (QIAGEN, CA, USA) according to the
manufacture’s protocol. 2 μg of RNA was used for the first strand cDNA synthesis by
Superscript III (Invitrogen). The primer sets for VEGF A, VEGF C, E-cadherin, and β-actin
are as follows: the VEGF A, sense 5′-CTCACCAAGGCCAGCACATAGG-3′ and anti-
Kalkunte et al. Page 3
Placenta. Author manuscript; available in PMC 2013 March 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
sense 5′-ATCTGGTTCCGAAAACCCTGAG-3′ (291 bp product); VEGF C, sense 5′-
GTCTGTGTCCAGTGTAGATG-3′ and anti-sense 5′-AGGTAGCTCGTGCTGGTGTT-3
(360 bp product); E-cadherin, sense 5′-TCC ATTTCTTGGTCTACGCC-3′ and anti-sense
5′-CACCTTCAGCCAACC TGTTT-3′ (530 bp product), and β-actin, sense 5′-
TCGACAACGGCTCCGGCA-3′ and anti-sense 5′-AAGGTGTGGTGCCAGATT-3′ (239
bp fragment). All the PCR reactions were conducted using GenAmp 9600 PCR system
(Perkin-Elmer, Norwalk, CT). The optimal RT-PCR conditions were standardized for each
product. PCR products were separated by electrophoresis on 2% agarose gels and stained
with ethidium bromide.
2.7. ELISA
Culture supernatant from trophoblast cell lines and primary trophoblasts (1×106/ml) was
collected 48hrs after plating. Concentrations of VEGF A, VEGF C, placenta growth factor
(PLGF), soluble Flt-1 (sFlt-1) and soluble Endoglin (sEng) were measured in triplicate by
ELISA (Quantikine Kits, R&D System, Minneapolis, MN, USA) according to the
manufacturers’ instructions. The results were normalized to protein concentration and
expressed in ng/ml. The intra- and inter-assay coefficients of variation were <10%.
2.8. Flow cytometry analysis
Cells were harvested, washed twice with PBS buffer containing 0.1% sodium azide and 1%
BSA. Cells were incubated in dark at 4°C for 30 min with appropriate antibodies. If
necessary, cells were washed, incubated with secondary antibody at 4°C for 30 minutes and
resuspended in PBS buffer. A total of 10,000 events were recorded and analyzed using
FACS Calibur ™ and WinMidi software (Becton Dickinson). Negative controls were
performed for each cell type by incubating the cells with isotype-matched control antibodies.
The anti-human mouse mAbs used for this study were FITC-conjugated HLA G (MEM-G/9
Abcam) and integrins (23C6, BD Biosciences), APC-conjugated αvβ3 CD31 (PECAM-1)
(WM59, eBioscience), PE-conjugated VE-Cadherin (16B1 eBioscience), VEGF R1, VEGF
R2 and VEGF R3 (R&D VEGF receptor sampler kit). For E-cadherin, we used goat anti-
human E-cadherin primary antibody (R&D System Inc) followed by PE conjugated anti-
goat IgG (Jackson Lab).
2.9. In vivo studies
A modified in vivo matrigel plug assay was performed as previously described [12]. Briefly,
a 600 μl mixture of endothelial cells (2×105) and growth factor reduced-matrigel
resuspended in 10% NPS were injected subcutaneously (s.c.) into nude mice that resulted in
the formation of palpable plugs. One hour later, 7.5×105 trophoblast cells (HTR8 or TCL1)
were injected at the rim of the matrigel plug. The matrigel plugs were excised 6 days post
injection; the cells were isolated using cell recovery solution (BD Biosciences) and stained
with HLA G monoclonal antibody to quantify the number of the invading trophoblasts by
flow cytometry.
2.10. Statistical analysis
Statistical significance of experimental differences was assessed using Student’s paired t-
tests. The differences were considered to be statistically significant when the p value was <
0.05.
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3. Results
3.1. Endothelial cells but not trophoblasts form tube-like capillary structures on matrigel
We examined the ability of endothelial and trophoblasts cells to form tube like capillary
structures on matrigel. Endothelial cells (HUVEC or HUtEC) and first trimester HTR8
trophoblasts, third trimester TCL1 trophoblasts, or term primary trophoblasts were cultured
independently on matrigel in the presence of NPS. Endothelial cells (panels a, b), but not
trophoblasts (panels c–e), migrated, polarized, underwent cytoskeleton remodeling,
branched and formed the classical capillary like tube formation (Fig. 1A). Under identical
culture conditions, trophoblasts failed to form tube like structures even after 72 hr of
incubation in the presence of NPS and rather remained aggregated as lumps or acinar
structures.
3.2. First trimester and third trimester trophoblasts exhibit differential interaction with
endothelial cells on matrigel
To understand the interactions of endothelial cells and trophoblasts, we examined the
response of trophoblasts to the presence of endothelial cells on matrigel in the presence of
NPS. When co-cultured, first trimester trophoblast HTR8 cells spontaneously
“fingerprinted” the capillary tube-like structures of HUtEC, (panel f, k) or HUVEC (panel g,
i). Similar results were obtained with another first trimester extravillous trophoblast cell line
Swan 71 (data not shown). Under identical conditions, third trimester TCL1 trophoblasts
(panel h) or primary trophoblasts (panel i) failed to participate in the capillary tube
formation (Fig 1A). On the contrary, these cells hindered the formation of tube structures by
endothelial cells. This distinct and unique interaction of first trimester trophoblasts
compared to term trophoblasts pointed to inherent differences in the expression of
angiogenic factors and/or their receptors or the adhesion molecules that promote or retard
cellular migration and interaction. The average number of vacuoles formed (indicated by
bold arrow) during the interactions of trophoblasts with HUVEC or HUtEC cells were
quantified and shown in Fig. 1B. Since HUtEC and HUVEC show similar behavior, further
experiments were carried out with HUVEC.
3.3. Differential expression of vascular endothelial growth factors in trophoblasts
The important growth factors that are central to angiogenesis belong to the vascular
endothelial growth factor (VEGF) family including VEGF A and VEGF C. We examined
mRNA expression of VEGF A and VEGF C in endothelial cells, HTR8, TCL1 and term
primary trophoblasts using semi-quantitative PCR. VEGF A was expressed in all three cell
lines as well as primary trophoblasts. In contrast, VEGF C was highly expressed in first
trimester HTR8 cells but not TCL1 cells or primary trophoblasts (Fig. 2A). Next, we
examined the concentrations of angiogenic factors in conditioned media of trophoblast cells
and HUVEC by ELISA. Only the first trimester HTR8 cells produced VEGF A and VEGF
C in significant amounts. On the other hand, TCL1 and term primary trophoblasts produced
only VEGF A at comparable levels to HTR8. PlGF was produced at low levels in all cells
studied. However, PlGF was the prominent secreted angiogenic factor by HUVEC cells
along with VEGF C and very low levels of VEGF A (Fig. 2B).
3.4. Expression of anti-angiogenic factors sFlt-1 and sEng and lack of VEGF receptors
regulate non interactive features of term trophoblasts
Despite the production of VEGF A, TCL1 cells and term primary trophoblasts fail to
participate in tube formation and block tube formation by endothelial cells. It is possible that
these cells have been programmed to express anti-angiogenic factors such as sFlt-1 that can
act as a decoy receptor for VEGF A, and soluble endoglin (sEng). These two biomarkers
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have been implicated in pre-eclampsia. Our data suggest that first trimester HTR8 cells did
not produce sFlt-1 while sEng was secreted at low levels (Fig. 3A). Term primary
trophoblasts secreted high amounts of sFlt-1 and sEng comparable to those produced by
endothelial cells. To our surprise, TCL1 cells did not intrinsically produce any significant
levels of sFlt-1 and sEng. A lack of sFlt-1 and sEng production by TCL1 cells does not
explain their poor participation in tube formation. It is possible that the block in interaction
with endothelial cells in tube formation is displayed at the level of VEGF receptor
expression.
Next, we examined by FACS analysis the surface expression of the VEGF receptors on
endothelial cells and trophoblasts (Fig. 3B–C). VEGF A predominantly signals through
VEGF R1 and VEGF R2, whereas VEGF C utilizes VEGF R2 and VEGF R3 for signaling.
We found that TCL1 cells and term primary trophoblasts minimally express all the three
VEGF receptors, implying that these cells are likely to be unresponsive to VEGFs and poor
partners in endovascular remodeling. In contrast, first trimester HTR8 cells express VEGF
R2 prominently, with moderate expression of VEGF R1 and VEGF R3. Likewise, HUVEC
cells were shown to express high levels of VEGF R1 along with VEGF R2 and VEGF R3.
3.5. E-cadherin is uniquely expressed in TCL1 cells and term primary trophoblasts
Cadherin encoded by the CDH5 gene is a Ca2+ dependent cell-cell adhesion molecule.
When expressed on epithelial cells, E-cadherin is thought to stabilize the epithelial
architecture by preventing invasion and by regulating the differentiation into a non-invasive
phenotype. On the other hand, endothelial cells preferentially express VE-cadherin, not
HLA G or E-cadherin (Fig. 4A). Recent studies suggest that invading trophoblasts undergo
phenotypic changes losing E-cadherin and acquiring VE-cadherin expression [18]. Thus, we
examined the expression of E-cadherin and VE-cadherin on trophoblasts by FACS and
semi-quantitative PCR (E-cadherin). We also compared HLA G expression. E-cadherin was
expressed abundantly on TCL1 cells and term trophoblasts but not on HTR8 cells both at
protein and at mRNA level (Fig. 4A–B). Although, the expression of HLA G, a putative
extravillous marker of trophoblasts, was intense and comparable, the endovascular marker
VE-cadherin was found to be poorly expressed on both first trimester and third trimester
trophoblasts (Fig. 4A). Taken together, our results indicate that the extent of E-cadherin
expression may guide the ability of trophoblast cells for migration and interaction with
endothelial cells.
3.6. Functional kinase activity of VEGF R2 is critical for endothelial cell-directed tube
formation by first trimester HTR8 trophoblasts
Since HTR8 cells dominantly express VEGF R2, we examined the effect of SU1498, a
specific VEGF R2 kinase inhibitor, on their in vitro interaction with endothelial cells as
described in Materials and Methods. In contrast to vehicle treated cells, HTR8 cells pre-
treated with SU1498 were detected at the branch points along the tubes, but did not
“fingerprint” the endothelial tube structures (Fig. 5a–c), indicating that signaling through
kinase activity of VEGF R2 is critical for the endothelial cell-trophoblast interaction, a
process required for spiral artery remodeling.
3.7. In vivo evidence for poor angiogenic potential of TCL1 trophoblasts
The data in Fig. 1 clearly demonstrate that TCL1 cells or term primary trophoblasts fail to
interact with endothelial cells in capillary tube formation. However, it is still possible that in
vitro conditions influenced their behavior. To rule out this possibility, we took advantage of
an in vivo assay that has been recently developed to study angiogenic properties of uterine
NK cells [12]. In this assay, uNK cells when present in a matrigel plug attract trophoblast
cells toward the plug. In our assay, we replaced uNK cells with HUVEC cells. Matrigel
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mixed with HUVEC cells (Fig. 6b, c, e) or matrigel without cells (Fig. 6a, d) was injected in
nude mice as described in Materials and Methods. HTR8 (Fig. 6a, b) or TCL1 cells (Fig. 6d,
e) resuspended in NPS were subsequently injected at the rim of the plug. Since HUVEC
cells do not express HLA G, we can easily assay for HLA G positive HTR8 and TCL1 cells
isolated from the matrigel plugs. As observed by FACS analysis (Fig. 6), only the first
trimester HTR8 cells were able to significantly invade the matrigel plugs in response to the
chemo-attracting signals from endothelial cells (Fig. 6b), while third trimester TCL1 cells
failed to invade the plugs (Fig. 6e). These data also clearly suggest that HTR8 invasion was
specifically triggered by HUVEC cells as no HTR8 cells migrated to matrigel plug if not
mixed with HUVEC cells (Fig. 6a). To confirm an angiogenic interaction between
endothelial cells and HTR8 cells, we targeted VEGF R2 activity on HTR8 cells. Thus, pre-
treatment of HTR8 cells with the specific VEGF R2 kinase inhibitor SU1498, abrogated the
migratory response of these cells (Fig. 6c).
4. Discussion
Single cell capillary tube formation using endothelial cells on three dimensional matrices
like collagen, fibronectin and matrigel has been used to study the processes involved in
angiogenesis [19]. Using a co-culture of endothelial cells and trophoblasts in this matrigel-
based culture system, we have developed an in vitro model that closely mimics the cell-cell
interactions at the maternal-fetal interface. This system allows cells to display the
phenotypic and morphological characteristics that they are likely to assume in vivo [19].
Several studies have suggested that gestational age-related presence of angiogenic factors,
cytokines, and hormones in maternal serum reflects intrauterine milieu. [20–25]. Thus,
serum can function as a “blueprint” for the events at the maternal-fetal interface.
In this study, endothelial cells, but not trophoblasts, typically formed tube-like capillary
structures in response to normal pregnancy serum (NPS). This suggests that NPS provides
physiologically relevant pregnancy-based factors which initiate interactions between cells
and morphological transformation. In co-culture studies, while HTR8 trophoblasts with
invading features were uniquely influenced by cues from endothelial cells and
“fingerprinted” endothelial cell-guided tube formation, third trimester TCL1 trophoblasts
and term primary trophoblasts failed to respond to either HUVEC or HUtEC endothelial
cells. Further, HTR8 cells introduced into pre-formed endothelial capillary network assume
tube like structures with faster kinetics and stabilized the endothelial cell architecture
possibly reflecting the initial stages of vascular remodeling in the spiral arteries, which is in
agreement with the findings of Aldo et al. [11]. Importantly, the ability of endothelial cells
to influence and guide trophoblasts was confirmed in vivo by using matrigel plug assay.
Only first trimester HTR8 trophoblasts not TCL1 trophoblasts or term primary trophoblasts
were able to invade in response to the angiogenic cues from the plug-entrapped endothelial
cells. These observations clearly imply that late pregnancy trophoblasts possibly undergo
intrinsic programming to lose their invasive properties and cell-cell interactions.
What could be the intrinsic properties and mechanistic underpinnings that abrogate invasion
and cell-cell interaction of third trimester trophoblasts? This biologically important
difference between first trimester and late pregnancy trophoblasts does not appear to stem
from differential expression of VE-cadherin, HLA G, αvβ3, and PECAM-1, as these
molecules are similarly expressed or not expressed between trophoblasts from different
gestational age (integrin and PECAM data not shown). Although VE-cadherin, HLA G,
αvβ3, and PECAM-1 have been implicated in promoting trophoblast migration and
invasiveness [18, 26,27], it is possible that they can be overtly compensated by modulation
of other adhesion molecules and VEGF machinery on third trimester trophoblasts.
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Our findings indicate that VEGF C is a signature angiogenic molecule expressed and
secreted by first trimester trophoblasts, but not TCL1 cells and term trophoblasts.
Interestingly, there is a striking association between tumor cells that produce VEGF C and
their invasive and metastatic potential [28]. Further, our findings support in part an earlier
report that invading cytotrophoblasts release VEGF C and PlGF which are critical
components to acquisition of the endovascular phenotype, uterine invasion and spiral artery
modification [29]. The VEGF family of angiogenic factors mediate their action by signaling
through their cognate receptors VEGF R1 (Flt-1), VEGF R2 (KDR/Flk-1), VEGF R3 (Flt-4)
[30]. Our findings indicate that unlike first trimester trophoblasts, primary term trophoblasts
and third trimester TCL1 cells expressed VEGF receptors poorly. While VEGF A
predominantly acts on VEGF R1 and VEGF R2, VEGF C functions through VEGF R2 and
VEGF R3. Increased expression of VEGF R1 that lacks the signal transducing kinase-
domain is observed in PE placenta [31]. This indicates that these trophoblasts would not be
able to respond to angiogenic cues from the surrounding cells and suggest the importance of
kinase activity for intracellular signaling. Our data strongly support this notion because
SU1498, a specific inhibitor of VEGF R2 kinase activity, blocked both in vivo and in vitro
the response of HTR8 cells to migrate or to interact with endothelial cells. Our findings
suggest that functional VEGF R2 is indispensable for an active trophoblast-endothelial
crosstalk. Similar observations have been reported for endothelial cells in angiogenesis and
tube formation [32].
Reduced placental expression of VEGF and PlGF are consistently observed in preeclampsia
[20, 21, 24, 25, 32]. Further, preeclampsia is frequently accompanied by enhanced
circulation and placental expression of sFlt-1, which acts as a decoy receptor titrating out
VEGFs and PlGF [21, 22,25]. In this study, we show that high levels of sFlt-1 are secreted
by term trophoblasts, shifting the net balance to favor anti-angiogenic activity as
demonstrated by inhibition of tube formation. This disruption was further accentuated by the
secretion of five fold higher amounts of soluble endoglin as compared with sFlt-1 levels.
The soluble form of endoglin (CD105), a co-receptor involved in TGFβ signaling is reported
to enhance the anti-angiogenic effects of sFlt-1 [23]. In addition, it is possible that TCL1
cells and term trophoblasts uniquely produce other effector molecules such as TGFβ that
inhibit formation of endothelial cell tube structures. HTR8 cells were shown to have no
endogenous TGFβ activity [15] whereas term trophoblasts have been shown to produce
much higher amounts of active TGFβ [33].
Down-regulation of E-cadherin expression is correlated with cell invasiveness particularly
during early tumor progression. E-cadherin is known to maintain differentiation and to
inhibit invasion [34]. In this regard, our findings of abundant expression of E-cadherin in
third trimester TCL1 cells and term trophoblasts, in contrast to first trimester HTR8 cells
point to its contribution to the differential interaction with endothelial cells. Likewise,
epigenetic regulation of E-cadherin has been associated with migratory or non-migratory
properties of the choriocarcinoma cell line, BeWo [35]. The BeWo cells intrinsically do not
express E-cadherin, but acquire it after treatment with 5-aza-2′-deoxycytidine (5-AZA), an
inhibitor of DNA methylation. Unlike choriocarcinoma BeWo cells, HTR8 cells did not
change their properties after treatment with 5-AZA (data not shown), suggesting that lack of
E-cadherin expression in HTR8 cells is not under the epigenetic regulation. However, the
results with BeWo cells support our findings on the role of E-cadherin in TCL1 cells or term
primary trophoblasts.
In summary, our findings strongly suggest that late pregnancy trophoblasts fail to participate
in endovascular remodeling due to poor expression of VEGF C and VEGF R2, elevated
production of anti-angiogenic factors, and robust expression of E-cadherin. Our findings
suggest that extravillous trophoblasts from late pregnancy cannot overcome shallow
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trophoblast invasion in late pregnancy as they fail to migrate and engage proactively with
spiral artery endothelial cells. The disparate behavior of first and third trimester trophoblasts
to the presence of endothelial cells can be exploited to decipher the important components in
the serum samples from adverse pregnancy outcomes.
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Figure 1. Representative photomicrographs of trophoblasts-endothelial cell interactions on
matrigel
(A) Endothelial cells (EC) and trophoblasts cells, labeled with red and green cell tracker
respectively, were independently (a–e) or co-cultured (f–i) on matrigel. Capillary like tube
structures were observed for HUtEC (a) and HUVEC (b) endothelial cells (shown by bold
arrow) but not for HTR8 (c), TCL1 (d), and term trophoblasts (e). However, in co-cultures,
HTR8 “fingerprint” the HUtEC (f) or HUVEC (g) while TCL1 cells (h) and primary term
trophoblasts (i) inhibited the tube formation by HUVEC (4x, magnification). Panels j–l
show co-cultures of HTR8 with HUVEC (j), HUtEC (k) and term trophoblasts with HUVEC
(l) at higher magnification (10x). The panels are a representative of experiments in triplicate
using 8 different NPS samples.
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(B) The average number of tubes/vacuoles formed was quantified in four different fields
(4x, magnification). The numbers (bars, +SD) are average of representative experiments
(with six NPS samples) in triplicate, assessed by two independent investigators. ** P < 0.05
as compared to HUVEC+HTR8 group.
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Figure 2. Term primary trophoblasts and TCL1 lack VEGF C expression
(A) Semi-quantitative RT-PCR using total RNA from HUVEC and trophoblasts was
performed to evaluate the expression of VEGF A and VEGF C using β-actin as a loading
control. This figure is representative of three different experiments. (B) Conditioned media
from HUVEC and trophoblast cells were evaluated for angiogenic factors by ELISA and
expressed as mean± SD. ** and # P < 0.05 as compared with HUVEC and HTR8 pair and
the HTR8 and TCL1 pair, respectively.
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Figure 3. Anti-angiogenic factors and lack of VEGF receptors contribute to poor interaction by
term trophoblasts
(A) Supernatants from cultured EC and trophoblasts were evaluated for sFlt-1 and sEng by
ELISA and the values are expressed as mean±SD from triplicate assays. (B) VEGF receptor
expression profiles are shown for HUVEC, HTR8, TCL1, and term primary trophoblasts.
(C) Quantitative analysis for FACS data represents the mean intensity from three different
experiments and is shown with standard deviation (bars, ±SD). * and # P < 0.05 for the
HUVEC and HTR8 pair and the HTR8 and TCL1 pair, respectively.
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Figure 4. E-cadherin expression contributes to poor endovascular activity of TCL1 and primary
term trophoblasts
(A) FACS analysis of E-cadherin, VE-cadherin and HLA G. (B) RT-PCR analysis of E-
cadherin expression in HTR8, TCL1 and primary term trophoblasts. Intense expression of E-
cadherin is observed in third trimester trophoblast cell line TCL1 and primary term
trophoblasts but not in first trimester HTR8 cells. A representative of three independent
experiments is shown.
Kalkunte et al. Page 16
Placenta. Author manuscript; available in PMC 2013 March 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5. Functional VEGF R2 is essential for endothelial-trophoblast interaction
HTR8 cells were pre-incubated with VEGF R2 kinase inhibitor SU1498 at 10 μM (b) or 20
μM (c) and then co-cultured on matrigel with HUVEC cells. Tube formation was evaluated
and compared to untreated control HTR8 and EC (a). Pretreatment of HTR8 cells with
SU1498 blocks their participation in tube formation. A representative from three
independent experiments is shown.
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Figure 6. In vivo matrigel plug assay for trophoblast-endothelial cell interactions
Nude mice (n=3 per group)) were injected s.c. with matrigel with or without HUVEC cells.
HTR8 or TCL1 trophoblasts were injected around the rim after 30 minutes. Representative
quantitative FACS analysis of HLA G+ trophoblasts entrapped in HUVEC containing plug
is indicated at the corner of each panel. (a) Control matrigel (no cells) +HTR8, (b) Matrigel-
entrapped HUVEC+HTR8, (c) Matrigel-entrapped HUVEC+SU1498-treated HTR8, (d)
Control matrigel+TCL1, and (f) Matrigel-entrapped HUVEC+TCL1.
Kalkunte et al. Page 18
Placenta. Author manuscript; available in PMC 2013 March 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
